Antibacterial Therapy in the Treatment of Acute and Chronic Bronchitis

Simple item page
dc.creatorUmarovich, Rustamov Oybek
dc.creatorRashidovich, Navruzov Rustam
dc.date2023-01-31
dc.date.accessioned2023-08-21T09:04:21Z
dc.date.available2023-08-21T09:04:21Z
dc.descriptionAcute infections account for more than 90% of all respiratory tract diseases in childhood [1]. Despite the availability of practical recommendations on the use of antibacterial drugs in children in outpatient practice [2], drugs of this type are often prescribed unreasonably, and therefore the issues of their rational use in the treatment of respiratory tract infections remain relevant. Since up to 70% of acute respiratory infections are viral in nature, they do not require antibacterial therapy. This provision applies to both most diseases of the upper respiratory tract and acute bronchitis. Prescribing antibiotics for respiratory viral infection does not reduce the duration of treatment and the number of complications, and unjustified prescribing increases the risk of side effects, disrupts the biocenosis and contributes to the spreadof drug resistance. Objective: to analyze the prescriptions of antibacterial drugs in the treatment of acute and chronic bronchitis.en-US
dc.formatapplication/pdf
dc.identifierhttps://univerpubl.com/index.php/scholastic/article/view/255
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/21795
dc.languageeng
dc.publisherUniver Publishingen-US
dc.relationhttps://univerpubl.com/index.php/scholastic/article/view/255/192
dc.sourceScholastic: Journal of Natural and Medical Education; Vol. 2 No. 1 (2023): Scholastic: Journal of Natural and Medical Education; 101-103en-US
dc.subjectantibacterial drugsen-US
dc.subjectbronchitisen-US
dc.titleAntibacterial Therapy in the Treatment of Acute and Chronic Bronchitisen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Scholastic: Journal of Natural and Medical Education